Amicus Therapeutics Inc
NASDAQ:FOLD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
US |
|
Cineplex Inc
TSX:CGX
|
CA |
|
S
|
Sriracha Construction PCL
SET:SRICHA
|
TH |
|
A
|
Amata VN PCL
SET:AMATAV
|
TH |
|
T
|
Tele Columbus AG
XHAM:TC1
|
DE |
|
F
|
Fuji Seal International Inc
TSE:7864
|
JP |
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
KR |
|
Unilever Indonesia Tbk PT
IDX:UNVR
|
ID |
|
A
|
Aditya Consumer Marketing Ltd
BSE:540146
|
IN |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
H
|
Hirose Electric Co Ltd
TSE:6806
|
JP |
|
M
|
Modulight Oyj
OMXH:MODU
|
FI |
|
Kobe Bussan Co Ltd
TSE:3038
|
JP |
Wall Street
Price Targets
FOLD Price Targets Summary
Amicus Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FOLD
is 15.81 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FOLD's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
FOLD
is 15.81 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
What is Amicus Therapeutics Inc's Revenue forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Amicus Therapeutics Inc's revenue is
27%.
The projected
CAGR
for the next 3 years is
20%.
What is Amicus Therapeutics Inc's Operating Income forecast?
Projected CAGR
124%
The
compound annual growth rate
of Amicus Therapeutics Inc's operating income for the next 3 years is
124%.
